These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 1970951)

  • 1. Synthesis and structure-activity relationships of [MeTyr1, MeArg7]-dynorphin A(1-8)-OH analogues with substitution at position 8.
    Yoshino H; Kaneko T; Arakawa Y; Nakazawa T; Yamatsu K; Tachibana S
    Chem Pharm Bull (Tokyo); 1990 Feb; 38(2):404-6. PubMed ID: 1970951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and biological activity of [MeTyr1,MeArg7,D-Leu8]-dynorphin A(1-9)-NHEt and [D-Cys2-Cys5,MeArg7,D-Leu8]-dynorphin A(1-9)-NH2.
    Yoshino H; Arakawa Y; Nakazawa T; Kaneko T; Matsunaga M; Araki S; Ikeda M; Tsuchiya Y; Yamatsu K; Tachibana S
    Chem Pharm Bull (Tokyo); 1990 Aug; 38(8):2274-6. PubMed ID: 1980641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and structure-activity relationships of dynorphin A-(1-8) amide analogues.
    Yoshino H; Nakazawa T; Arakawa Y; Kaneko T; Tsuchiya Y; Matsunaga M; Araki S; Ikeda M; Yamatsu K; Tachibana S
    J Med Chem; 1990 Jan; 33(1):206-12. PubMed ID: 1967312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [2',6'-Dimethyltyrosine]dynorphin A(1-11)-NH2 analogues lacking an N-terminal amino group: potent and selective kappa opioid antagonists.
    Lu Y; Nguyen TM; Weltrowska G; Berezowska I; Lemieux C; Chung NN; Schiller PW
    J Med Chem; 2001 Sep; 44(19):3048-53. PubMed ID: 11543672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design of potent dynorphin A-(1-9) analogues devoid of supraspinal motor effects in mice.
    Le HT; Michelot R; Dumont M; Shukla VK; Mayer M; Nguyen KP; Ruan H; Lemaire S
    Can J Physiol Pharmacol; 1997 Jan; 75(1):9-14. PubMed ID: 9101059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of modifications of residues in position 3 of dynorphin A(1-11)-NH2 on kappa receptor selectivity and potency.
    Lung FD; Meyer JP; Lou BS; Xiang L; Li G; Davis P; DeLeon IA; Yamamura HI; Porreca F; Hruby VJ
    J Med Chem; 1996 Jun; 39(13):2456-60. PubMed ID: 8691442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rational design of dynorphin A analogues with delta-receptor selectivity and antagonism for delta- and kappa-receptors.
    Guerrini R; Capasso A; Marastoni M; Bryant SD; Cooper PS; Lazarus LH; Temussi PA; Salvadori S
    Bioorg Med Chem; 1998 Jan; 6(1):57-62. PubMed ID: 9502105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Synthesis and biological activity of dynorphin A-(1-13) analogs].
    Chen YL; Zhong MN; Nie ZZ; Dong YX
    Yao Xue Xue Bao; 1995 Dec; 30(12):904-9. PubMed ID: 8712016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and opioid activity of 2-substituted dynorphin A-(1-13) amide analogues.
    Story SC; Murray TF; Delander GE; Aldrich JV
    Int J Pept Protein Res; 1992 Aug; 40(2):89-96. PubMed ID: 1359999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and biological activity of analogs of dynorphin-A(1-13) substituted in positions 2 and 4: design of [Ala2,Trp4]-Dyn-A(1-13) as a putative selective opioid antagonist.
    Lemaire S; Turcotte A
    Can J Physiol Pharmacol; 1986 Jun; 64(6):673-8. PubMed ID: 2875777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and synthesis of highly potent and selective cyclic dynorphin A analogues.
    Kawasaki AM; Knapp RJ; Kramer TH; Wire WS; Vasquez OS; Yamamura HI; Burks TF; Hruby VJ
    J Med Chem; 1990 Jul; 33(7):1874-9. PubMed ID: 1972964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis, and biological activities of cyclic lactam peptide analogues of dynorphine A(1-11)-NH2.
    Lung FD; Collins N; Stropova D; Davis P; Yamamura HI; Porreca F; Hruby VJ
    J Med Chem; 1996 Mar; 39(5):1136-41. PubMed ID: 8676350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of highly potent and selective dynorphin A analogues as new medicines.
    Lung FD; Chen CH; Liu JH
    J Pept Res; 2005 Nov; 66(5):263-76. PubMed ID: 16218994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and synthesis of highly potent and selective cyclic dynorphin A analogs. 2. New analogs.
    Kawasaki AM; Knapp RJ; Kramer TH; Walton A; Wire WS; Hashimoto S; Yamamura HI; Porreca F; Burks TF; Hruby VJ
    J Med Chem; 1993 Mar; 36(6):750-7. PubMed ID: 8096246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis, and biological properties of highly potent cyclic dynorphin A analogues. Analogues cyclized between positions 5 and 11.
    Meyer JP; Collins N; Lung FD; Davis P; Zalewska T; Porreca F; Yamamura HI; Hruby VJ
    J Med Chem; 1994 Nov; 37(23):3910-7. PubMed ID: 7966152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and biological activity of dynorphin-(1-13) and analogs substituted in positions 8 and 10.
    Lemaire S; Lafrance L; Dumont M
    Int J Pept Protein Res; 1986 Mar; 27(3):300-5. PubMed ID: 2872177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pro(3)]Dyn A(1-11)-NH(2): a dynorphin analogue with high selectivity for the kappa opioid receptor.
    Schlechtingen G; Zhang L; Maycock A; DeHaven RN; Daubert JD; Cassel J; Chung NN; Schiller PW; Goodman M
    J Med Chem; 2000 Jul; 43(14):2698-702. PubMed ID: 10893307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A large-scale synthesis of [MeTyr1, MeArg7, D-Leu8]dynorphin A-(1-8)-NHEt (E-2078) by application of the trifluoroacetic acid-pentamethylbenzene deprotecting procedure in the final stage.
    Yoshino H; Tsujii M; Kodama M; Komeda K; Niikawa N; Tanase T; Asakawa N; Nose K; Yamatsu K
    Chem Pharm Bull (Tokyo); 1990 Jun; 38(6):1735-7. PubMed ID: 1976444
    [No Abstract]   [Full Text] [Related]  

  • 19. Evidence that dynorphin-(1-13) acts as an agonist on opioid kappa-receptors.
    Oka T; Negishi K; Suda M; Sawa A; Fujino M; Wakimasu M
    Eur J Pharmacol; 1982 Jan; 77(2-3):137-41. PubMed ID: 6277659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynorphin B-29: chemical synthesis and pharmacological properties in opioid systems in vitro.
    Sanchez-Blazquez P; Chang JK; Garzon J; Lee NM
    Neuropeptides; 1984 Sep; 4(5):369-74. PubMed ID: 6149489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.